The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations von Leach, M O, Brindle, K M, Evelhoch, J L, Griffiths, J R, Horsman, M R, Jackson, A, Jayson, G C, Judson, I R, Knopp, M V, Maxwell, R J, McIntyre, D, Padhani, A R, Price, P, Rathbone, R, Rustin, G J, Tofts, P S, Tozer, G M, Vennart, W, Waterton, J C, Williams, S R, Workman, P

Volltext

EE641 Economic and Health-Related Quality of Life Consequences of Imaging and Surveillance Schedule in Seminoma Testis von Huo, D, Cafferty, FH, Huddart, R, Joffe, J, Kaplan, RS, Murphy, L, Noor, D, Rustin, GJ, Schiavone, F, Sohaib, A, Swift, S, Sculpher, M, Saramago, P

Volltext

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856) von NEWLANDS, E. S, BLACKLEDGE, G. R. P, GIBSON, A. C, SLACK, J. A, RUSTIN, G. J. S, SMITH, D. B, STUART, N. S. A, QUATERMAN, C. P, HOFFMAN, R, STEVENS, M. F. G, BRAMPTON, M. H

Volltext

Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI von Maxwell, Ross J., Wilson, John, Prise, Vivien E., Vojnovic, Borivoj, Rustin, Gordon J., Lodge, Martin A., Tozer, Gillian M.

Volltext

Secondary tumours following etoposide containing therapy for germ cell cancer von Boshoff, C., Begent, R. H. J., Oliver, R. T. D., Rustin, G. J., Newlands, E. S., Andrews, R., Skelton, M., Holden, L., Ong, J.

Volltext

High-dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels von Kanfer, EJ, McGuigan, D, Samson, D, Abboudi, Z, Abrahamson, G, Apperley, JF, Chilcott, S, Craddock, C, Davis, J, MacDonald, C, Macdonald, D, Olavarria, E, Philpott, N, Rustin, GJ, Seckl, MJ, Sekhar, M, Stern, S, Newlands, ES

Volltext

A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma von Shamash, J, Syed, R, Sarker, S-J, Sarwar, N, Sharma, A, Mutsvangwa, K, Coetzee, C, Wilson, P, Rustin, GJ

Volltext bestellen

Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer von KERR, D. J, RUSTIN, G. J, KAYE, S. B, SELBY, P, BLEEHEN, N. M, HARPER, P, BRAMPTON, M. H

Volltext

Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma: I. Clinical and vascular studies von O'REILLY, S. M, RUSTIN, G. J. S, FARMER, K, BURKE, M, HILL, S, DENEKAMP, J

Volltext

No Increase in Second Tumors after Cytotoxic Chemotherapy for Gestational Trophoblastic Tumors von Rustin, Frances, Rustin, Gordon J. S, Dent, Joan, Booth, Margaret, Salt, Sandra, Bagshawe, Kenneth D

Volltext

The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations von Leach, MO, Brindle, KM, Evelhoch, JL, Griffiths, JR, Horsman, MR, Jackson, A, Jayson, GC, Judson, IR, Knopp, MV, Maxwell, RJ, McIntyre, D, Padhani, AR, Price, P, Rathbone, R, Rustin, GJ, Tofts, PS, Tozer, GM, Vennart, W, Waterton, JC, Williams, SR, Workmanw, P

Volltext

Phase I study of intravenous 4-hydroxyanisole von Rustin, Gordon J., Stratford, Michael R., Lamont, Alan, Bleehen, Norman, Philip, Philip A., Howells, Nest, Watfa, Rodeina R., Slack, John A.

Volltext

Phase II trials of rhizoxin in advanced ovarian, colorectal and renal cancer: Clinical Oncology/Epidemiology von Kerr, DJ, Rustin, GJ, Kaye, SB, Selby, P, Bleehen, NM, Harper, P, Brampton, MH

Volltext

Flavone acetic acid (FAA) with recombinant interleukin-2 (rIL-2) in advanced malignant melanoma: I. Clinical and vascular studies: Clinical Oncology/Epidemiology von O'Reilly, SM, Rustin, GJ, Farmer, K, Burke, M, Hill, S, Denekamp, J

Volltext

Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer von KAYE, S. B, BRAMPTON, M, HARPER, P, SMYTH, J, KERR, D. J, GORE, M, GREEN, J. A, GILBY, E, CRAWFORD, S. M, RUSTIN, G. J

Volltext

Studies on the subcellular localization of human neutrophil alkaline phosphatase von Rustin, G J, Wilson, P D, Peters, T J

Volltext

Phase II trials of fosquidone, (GR63178A), in colorectal, renal and non-small cell lung cancer: Clinical Oncology/Epidemiology von Kaye, SB, Brampton, M, Harper, P, Smyth, J, Kerr, DJ, Gore, M, Green, JA, Gilby, E, Crawford, SM, Rustin, GJ

Volltext

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856): Clinical Oncology/Epidemiology von Newlands, ES, Blackledge, GRP, Slack, JA, Rustin, GJ, Smith, DB, Stuart, NS, Quarterman, CP, Hoffman, R, Stevens, MFG, Brampton, MH, Gibson, AC

Volltext

Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer von RUSTIN, Gordon J. S, BAST, Robert C, KELLOFF, Gary J, BARRETT, J. Carl, CARTER, Stephen K, NISEN, Perry D, SIGMAN, Caroline C, PARKINSON, David R, RUDDON, Raymond W

Volltext

Biomarkers, surrogate end points, and the acceleration of drug development for cancer prevention and treatment: An update von KELLOFF, Gary J, BAST, Robert C, WOUDE, George F, COFFEY, Donald S, D'AMICO, Anthony V, KERBEL, Robert S, PARK, John W, RUDDON, Raymond W, RUSTIN, Gordon J. S, SCHILSKY, Richard L, SIGMAN, Caroline C

Volltext